Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer [Phase 1]
An update on a Phase I gene therapy trial of FP253/Fludarabine for prostate cancer. The study is sponsored by Biotech Equity Partners Pty Lt…
-
FDA approval · 2011-06-30FDA Approved: BICALUTAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical's Bicalutamide, resulting in updated labeling for this generic antiandrogen. …
-
FDA approval · 2011-06-29FDA Approved: DOCETAXEL — Original Application (Baxter Healthcare Corporation)
FDA approved the original application for docetaxel by Baxter Healthcare Corporation, marking its initial U.S. approval as a cancer therapy.…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AT-101 in combination with docetaxel and prednisone for hormone-refractory prostate cancer has complet…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 trial assessing the combination of docetaxel (Taxotere) and imatinib mesylate (Gleevec) in hormone-refractory prostate cancer wa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy [Phase 2]
Phase 2 study of erlotinib in non-metastatic prostate cancer with rising PSA on hormone therapy has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease [Phase 2]
Phase 2 study evaluating safety and effects of saracatinib (AZD0530) in breast and prostate cancer subjects with metastatic bone disease; re…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer [Phase 2]
Phase 2 trial comparing MDX-010 (ipilimumab) alone and with docetaxel in hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Evaluation of MRI for Prostate Cancer
The clinical trial evaluating MRI for prostate cancer conducted at Sheba Medical Center has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue [Phase 2]
This Phase 2 trial update compares Organic Germanium to placebo for preventing radiation-induced fatigue in patients with localized breast o…
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Novel Peptide Vaccination for Patients With Advanced Prostate Cancer [Phase 1, Phase 2]
Ongoing early-phase clinical trial updates on a novel peptide vaccination for advanced prostate cancer, spanning Phase 1 and Phase 2 stages.
-
CLINICAL_TRIALS research · 2011-06-22Clinical Trial Update: The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing [Phase 3]
The BIOPRES trial is a Phase 3 study comparing end-versus side-firing transrectal prostate biopsies. The current status is UNKNOWN and Amphi…
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer [Phase 2]
This Phase 2 trial evaluated two doses of conjugated estrogens (Premarin) in patients with prostate cancer that is resistant to androgen dep…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer [Phase 2]
A Phase 2 pilot efficacy study evaluating PI-88 in combination with docetaxel for prostate cancer has completed.
-
FDA approval · 2011-06-14FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) by AbbVie, expanding its approved indications and labeling.
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men [Phase 4]
A Phase 4 clinical trial update assesses whether dutasteride (Avodart) can extend time to progression in men with low-risk, localized prosta…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy [Phase 2]
A Phase II trial evaluating adjuvant docetaxel in men at high risk of relapse following prostatectomy has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases [Phase 2]
Phase 2 trial of tandutinib in progressive prostate cancer with bone metastases completed; results were posted in June 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project [NA]
A clinical trial update indicates the Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy [Phase 1]
Phase 1 clinical trial evaluating MRI-targeted focal laser thermal therapy for prostate cancer followed by radical prostatectomy has complet…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: E3-Hormone Refractory Prostrate Cancer Taxotere Combination [Phase 2]
Phase 2 clinical trial evaluating a Taxotere (docetaxel) combination for hormone-refractory metastatic prostate cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy [Phase 2]
A Phase 2 trial evaluating Zactima (vandetanib) versus placebo in prostate cancer patients on intermittent androgen deprivation therapy was …
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer [Phase 1]
Phase 1 pharmacokinetic study evaluating sorafenib (BAY43-9006) in combination with docetaxel (Taxotere) for prostate cancer has completed.
-
FDA approval · 2011-05-19FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triprorelin pamoate) submitted by Verity Pharmaceuticals Inc. The action indicates app…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Aggressive Prostate Cancers in Elderly Patients
This clinical trial update notes a completed study from Seoul National University Hospital investigating aggressive prostate cancers in elde…